A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Rodrigues, George ^a,e   Yartsev, Slav ^a   Tay, Keng Y ^b   Pond, Gregory R ^c   Lagerwaard, Frank ^d   Bauman, Glenn ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c Escarpment Cancer Research Institute   (Canada)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e NONE   (Canada)

Author keywords

Brain metastases; Clinical trial; Phase II; Radiosurgery; Radiotherapy

Indexed keywords

ADULT; ARTICLE; BRAIN METASTASIS; CLINICAL ASSESSMENT; CLINICAL RESEARCH; COGNITION; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METHODOLOGY; MULTICENTER STUDY; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STEREOTACTIC RADIOSURGERY; TOMOTHERAPY; TOXICITY; TREATMENT RESPONSE; BRAIN TUMOR; CLINICAL TRIAL; METASTASIS; SKULL IRRADIATION;

BRAIN NEOPLASMS; CRANIAL IRRADIATION; HUMANS; RESEARCH DESIGN;

EID: 84858602763     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-42     Document Type: Article

References (20)

1. Tsao MN, Lloyd NS, Wong RK, Rakovitch E, Chow E, Laperriere N. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 2005, 31:256-73. 10.1016/j.ctrv.2005.04.007, 15951117.
2. Gaspar L, Scott CB, Rotman M, et al. Recursive partitioning analysis of prognostic factors in three radiation oncology group (RTOG) brain metastasis trials. Int J Rad Oncol Biol Phys 1997, 37:745-751.
3. Sperduto PW, Berkey B, Gaspar LE, et al. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008, 70:510-514. 10.1016/j.ijrobp.2007.06.074, 17931798.
4. Mehta MP, Tsao MN, Whelan TJ, et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005, 63:37-46. 10.1016/j.ijrobp.2005.05.023, 16111570.
5. Lightstone AW, Benedict SH, Bova FJ, Solberg TD, Stern RL. Intracranial stereotactic positioning systems: report of the American Association of Physicists in Medicine Radiation Therapy Committee Task Group no. 68. Med Phys 2005, 32:2380-98. 10.1118/1.1945347, 16121596.
6. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Rad Oncol Biol Phys 1999, 45:427-34.
7. Andrews D, Scott CB, Sperduto PW, Flanders A, Gaspar L, Schell M, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665. 10.1016/S0140-6736(04)16250-8, 15158627.
8. Hall EJ, Brenner DJ. The radiobiology of radiosurgery: rationale for different treatment regimes for AVMs and malignancies. Int J Radiat Oncol Biol Phys 1993, 25:381-5. 10.1016/0360-3016(93)90367-5, 8420891.
9. Chase D, Ramsey C, Maha S. The impact of inter- and intra-fraction motion in image guided helical tomotherapy. Int J Rad Oncol Biol Phys 2004, 60:S619.
10. Mackie TR, Balog J, Ruchala K, Shepard D, Aldridge S, Fitchard E, et al. Tomotherapy. Semin Radiat Oncol 1999, 9:108-17. 10.1016/S1053-4296(99)80058-7, 10210549.
11. Beavis AW. Is tomotherapy the future of IMRT?. Br J Radiol 2004, 77:285-95. 10.1259/bjr/22666727, 15107318.
12. Bauman G, Yartsev S, Rodrigues G, et al. A prospective evaluation of helical tomotherapy. Int J Radiat Oncol Biol Phys 2007, 68:632-641. 10.1016/j.ijrobp.2006.11.052, 17321068.
13. Podgorsak EB, Pike GB, Olivier A, Pla M, Souhami L. Radiosurgery with high energy photon beams: a comparison among techniques. Int J Radiat Oncol Biol Phys 1989, 16:857-65. 10.1016/0360-3016(89)90506-3, 2493438.
14. Ma L, Xia P, Verhey LJ, Boyer AL. A dosimetric comparison of fan-beam intensity modulated radiotherapy with gamma knife stereotactic radiosurgery for treating intermediate intracranial lesions. Int J Rad Oncol Biol Phys 1999, 45:1325-30.
15. Bolsi A, Fogliata A, Cozzi L. Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: a treatment planning study. Radiother Oncol 2003, 68:1-14. 10.1016/S0167-8140(03)00117-8, 12885446.
16. Khoo VS, Oldham M, Adams EJ, Bedford JL, Webb S, Brada M. Comparison of intensity-modulated tomotherapy with stereotactically guided conformal radiotherapy for brain tumors. Int J Radiat Oncol Biol Phys 1999, 45:415-25.
17. Shaw E, Scott C, Souhami L, Dinapoli R, Bahary J-P, Kline R, et al. Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol 90-05. Int J Rad Oncol Biol Phys 1996, 34:647-54.
18. Bauman G, Yartsev S, Fisher B, Kron T, Laperriere N, Heydarian M, VanDyk J. Simultaneous infield boost with helical tomotherapy for patients with 1 to 3 brain metastases. Am J Clin Oncol 2007, 30:38-44. 10.1097/01.coc.0000245473.41035.c4, 17278893.
19. Rodrigues G, Yartsev S, Yaremko B, Perera F, Dar AR, Hammond A, et al. Phase I trial of simultaneous in-field boost with helical tomotherapy for patients with one to three brain metastases. Int J Radiat Oncol Biol Phys 2011, 80:1128-33. 10.1016/j.ijrobp.2010.03.047, 20675078.
20. Rodrigues G, Eppinga W, Lagerwaard F, de Haan P, Haasbeek C, Perera F, et al. A pooled analysis of arc-based image-guided simultaneous integrated boost radiation therapy for oligometastatic brain metastases. Radiother Oncol 2012, 102:180-6. 10.1016/j.radonc.2011.05.032, 21641067.